@HoppeBrad Profile picture

Bradford Hoppe

@HoppeBrad

One-wheeler, lympho-maniac, Particle therapy guru, rad onc researcher, husband, dad x3 boys. Livin’ the beach/salt life. tweets=mine

Similar User
Dan Trifiletti, MD photo

@DanTrifMD

James Bates photo

@JamesBatesMD

Daniel Ma photo

@DanielMaMD

Bouthaina Dabaja MD photo

@BouthainaDabaja

Nadia Laack, MD MS photo

@n_laack

Raymond Mailhot photo

@raymailhotvega

Jeff Bradley, MD photo

@JeffBradleyMD

Allison Garda photo

@allisongardaMD

Bruce Haffty photo

@BHaffty

Elaine M. Zeman, PhD photo

@DrZeman

Mark V. Mishra photo

@MarkMishraMD

Mark Storey photo

@ProtonStorey

Steven H. Lin photo

@StevenLin_MDPhD

Jason Beckta photo

@drbeckta

Kim Corbin photo

@KimCorbinMD

Another set of great images from @OmranSaifi to show how RT has evolved in management of lymphoma. Thanks Dr Diefenbach for the opportunity to share.

💡Reminder: Contemporary #radiotherapy for #lymphoma has evolved significantly! Radiation fields are much SMALLER, doses are LOWER, and techniques are more CONFORMAL—resulting in much LOWER toxicity while still achieving significant improvements in PFS! doi.org/10.1053/j.semi…

Tweet Image 1
Tweet Image 2


Bradford Hoppe Reposted

NEW Viewpoint—#Radiation target nomenclature for #lymphoma trials: consensus recommendations from the National Clinical Trials Network groups #radonc #lymsm thelancet.com/journals/lanha…



@SarahMilgrom⁩ great job presenting ⁦@COGorg⁩ ⁦ 0431 transplant-free salvage for low risk Hodgkin lymphoma. ⁩⁦@DrDHodgson⁩ ⁦@KaraKellyMD⁩ ⁦@SharonCastelli2

Tweet Image 1

@OmranSaifi⁩ receiving ⁦@ASTRO_org#ROI presents publication award for his work on CAR T cell therapy and RT for NHL ⁦@MayoCancerCare⁩ ⁦@MayoFL_RORes⁩ I’m a proud mentor.

Tweet Image 1

Congrats, Dr. Ebner!

Did you miss that we recently funded our 2024 #sarcoma research grants? None of these grants would be possible without the efforts that all of you put in every day to help fund research. Read about all of the grants here: buff.ly/3WDHxwT #CureSarcoma #cancer

Tweet Image 1


Bradford Hoppe Reposted

We highlight @JCO_ASCO the importance of addressing RT tox that matters most to pts when comparing proton to IMRT for prostate ca. Protons can⬇️ low dose bath➡️reduce bowel freq/urg—two most bothersome tox for pts. @HoppeBrad @albertattia7 @MayoCancerCare doi.org/10.1200/jco.24…


Bradford Hoppe Reposted

Online registration for the 10th Annual Meeting of PTCOG-NA is now open! The conference will be held in New York City on November 14-16, 2024. Take advantage of the Early Bird Registration rates available until August 29, 2024. bit.ly/3LnGQRF

Tweet Image 1

Excited to finally open Poseidon Trial after 2 years of hard work with resident @OmranSaifi . RCT 9Gy (3x3) vs 24Gy in indolent lymphoma. First patient enrolled and randomized last week. @MayoFL_RORes @MayoCancerCare @wgbreen @TheColonelGray clinicaltrials.gov/study/NCT06386…


Exciting work by Star resident Brady Laughlin, soon to be Mayo Faculty. Great mentorship by William Rule. ⁦@TheColonelGray@wgbreen⁩ Fine-Tuning Low-Dose Total Skin Electron Therapy for Optimal Management of Cutaneous T-Cell Lymphoma advancesradonc.org/article/S2452-…


Celebrating my recently awarded FACR with former ACR gold medalist Rich Hoppe and Mom. #ACR2024@ACRCARROS1986

Tweet Image 1

⁦⁦ Florida Rad Onc representing #ACR2024@ACRCARROS1986⁩ ⁦@MayoRadOnc⁩ ⁦@LauraVallow⁩ and Jennifer Peterson

Tweet Image 1

Bradford Hoppe Reposted

Particle therapy experts and thought leaders met at #MayoClinicFL's inaugural Heavy Ion Therapy Symposium to share ideas and collaborate. As we build the first #CarbonIon treatment facility in the Americas, we aim to ensure the future is full of hope and new options for patients.

Tweet Image 1

Excited to announce our first international site activation of the PROSPER study- CIRT vs Surgery for pelvic bone sarcomas. Thanks CNAO! Adroterapia, Mayo Clinic sceglie CNAO per il primo studio Usa su ioni carbonio tecnicaospedaliera.it/adroterapia-ma… via @Tecnica Ospedaliera


Bradford Hoppe Reposted

So proud of our very own Dr. Oladeru!! #radonc @MayoCancerCare @MayoClinic @ASTRO_org

Together with BMS Foundation and the NCTN cooperative groups, we’re proud to announce the first Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Award powered by #ConquerCancer’s EveryGrant for #DiversityInClinicalTrials. brnw.ch/21wFdMk

Tweet Image 1


⁦⁦@OmranSaifi⁩ at ⁦@ASH_hematology⁩ showing the importance of RT as part of bridging therapy with CAR T cell tx for nhl.⁦@MayoFL_RORes⁩ ⁦@MayoCancerCare

Tweet Image 1
Tweet Image 2

Heavy Ion Therapy Symposium - Register for January 25-26, 2024 Interested in Heavy Ion Therapy- Please attend - Jacksonville,FL ⁦⁦@MayoRadOnc⁩ ⁦@MayoCancerCare⁩ ⁦@PTCOGNA⁩ ⁦@PTCOG_Official⁩ ⁦@naptprotonsapp.e.response.mayoclinic.org/e/es?s=7488180…


Bradford Hoppe Reposted
Tweet Image 1

@PTCOGNA⁩ ⁦@JYangMDPhD⁩ presenting proton CSI for leptomeningeal disease

Tweet Image 1

Dr.Petruccelli and ⁦@detsang⁩ representing Princess Margaret Cancer Center ⁦@PTCOGNA⁩ great to have our Canadian colleagues participating

Tweet Image 1

Another ⁦@ASTRO_org#ASTRO23 means another CART related RT oral by ⁦@OmranSaifi⁩ Great Job ⁦@MayoFL_RORes@MayoRadOnc⁩ is proud!!

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.